Early research (Phase 1)Study completedNCT03654716
What this trial is testing
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Who this might be right for
LeukemiaBrain TumorSolid Tumor+1 more
Dana-Farber Cancer Institute 21